Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58,548,563
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
24,872,441
-
Shares change
-
+1,319,825
-
Total reported value, excl. options
-
$191,538,348
-
Value change
-
+$24,104,114
-
Put/Call ratio
-
46.47%
-
Number of buys
-
37
-
Number of sells
-
-50
-
Price
-
$7.7
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q3 2022
99 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q3 2022.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,872,441 shares
of 58,548,563 outstanding shares and own 42.48% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (3,400,503 shares), Cormorant Asset Management, LP (2,181,115 shares), JANUS HENDERSON GROUP PLC (2,174,725 shares), TANG CAPITAL MANAGEMENT LLC (1,967,051 shares), Candriam S.C.A. (1,910,333 shares), MORGAN STANLEY (1,647,752 shares), VANGUARD GROUP INC (1,408,232 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (860,200 shares), BlackRock Inc. (801,647 shares), and EVENTIDE ASSET MANAGEMENT, LLC (795,000 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.